Form 4: Eastman Chemical Co Director James J. O'Brien Reports Acquisition of Phantom Stock Units

Director James J. O'Brien reports acquisition of 412 Phantom Stock Units in Eastman Chemical Co under the Directors' Deferred Compensation Plan.

Summary

• James J. O'Brien, a director of Eastman Chemical Co, filed a Form 4 on April 9, 2025, reporting a transaction on April 7, 2025.
• The transaction involved the acquisition of 412 Phantom Stock Units under the Directors' Deferred Compensation Plan.
• These units have a value equal to the market value of one share of Eastman Chemical Co common stock and are payable in cash after termination of service as a director.
• The acquisition is due to the automatic deferral of a portion of the director's annual retainer fees into the director's stock account of the Directors' Deferred Compensation Plan.
• Following the reported transaction, O'Brien beneficially owns 16,525 derivative securities, which includes 473 units credited since October 7, 2024, as hypothetical reinvestment of dividend equivalents.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The director is increasing their stake in the company through a deferred compensation plan, which suggests confidence in the company's future performance. However, it's a routine transaction.

Positives

• The acquisition of Phantom Stock Units aligns the director's interests with the long-term performance of the company.
• The Directors' Deferred Compensation Plan allows for the deferral of fees into stock, indicating confidence in the company's future.

Future Outlook

The document does not contain specific forward-looking statements, but the director's participation in the deferred compensation plan suggests a positive outlook on the company's stock performance.

Industry Context

Directors' deferred compensation plans are a common practice in publicly traded companies to align the interests of directors with those of shareholders. This filing reflects standard regulatory reporting for such transactions.

Comparison to Industry Standards

• Deferred compensation plans for directors are a common practice among publicly traded companies, including Eastman Chemical Co's peers in the chemical industry such as Dow Chemical, BASF, and LyondellBasell.
• The structure of Eastman's plan, where units are valued at the market price of common stock and payable in cash after service termination, is typical of these arrangements.
• Similar plans are often benchmarked against industry standards to ensure competitiveness and alignment with shareholder interests.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders.
• It reinforces the alignment of director interests with shareholder value.

Key Dates

Keywords

Form 4, Director, Phantom Stock Units, Eastman Chemical Co, Deferred Compensation Plan, EMN, Beneficial Ownership